Paper23029232
Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.
Hashemi H and 6 others. PLoS One, 2012. Cited by 75 papers, by iCite.
Cite this record
ConductScience Library. Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge. Papers, record 23029232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23029232
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacteriophage T7 | Major topic |
| Influenza A virus | Major topic |
| Influenza Vaccines | Major topic |
| Influenza, Human | Major topic |
| Vaccination | Major topic |
| Viral Matrix Proteins | Major topic |
| Adjuvants, Immunologic | |
| Analysis of Variance | |
| Animals | |
| Antibodies, Viral | |
| Cells, Cultured | |
| Female | |
| Freund's Adjuvant | |
| Humans | |
| Immunoglobulin G | |
| Interferon-gamma | |
| Lung | |
| Mice | |
| Mice, Inbred BALB C | |
| Nanoparticles | |
| Spleen | |
| T-Lymphocytes | |
| Viral Load | |
| Viroporin Proteins |
Source PubMed
References73
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16029917 | The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine model. | Vaccine | 2005 | https://conductscience.org/library/papers/16029917 | PubMed |
| 2 | 18063235 | Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. | Vaccine | 2008 | https://conductscience.org/library/papers/18063235 | PubMed |
| 3 | 17081627 | Bacteriophage T4 nanoparticle capsid surface SOC and HOC bipartite display with enhanced classical swine fever virus immunogenicity: a powerful immunological approach. | J Virol Methods | 2007 | https://conductscience.org/library/papers/17081627 | PubMed |
| 4 | 20177411 | A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody. | Immunol Cell Biol | 2010 | https://conductscience.org/library/papers/20177411 | PubMed |
| 5 | 21169548 | Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection. | J Immunol | 2011 | https://conductscience.org/library/papers/21169548 | PubMed |
| 6 | 1126573 | Assessment of immunity to influenza using artifical challenge of normal volunteers with influenza virus. | Dev Biol Stand | 1975 | https://conductscience.org/library/papers/1126573 | PubMed |
| 7 | 6153930 | Complete structure of the hemagglutinin gene from the human influenza A/Victoria/3/75 (H3N2) strain as determined from cloned DNA. | Cell | 1980 | https://conductscience.org/library/papers/6153930 | PubMed |
| 8 | 20466528 | New adjuvants for human vaccines. | Curr Opin Immunol | 2010 | https://conductscience.org/library/papers/20466528 | PubMed |
| 9 | 16552087 | Protective CD8+ T cells induced by malaria sporozoites do not undergo modulation of interleukin-7 receptor expression. | Infect Immun | 2006 | https://conductscience.org/library/papers/16552087 | PubMed |
| 10 | 16315228 | Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier. | J Pharm Sci | 2006 | https://conductscience.org/library/papers/16315228 | PubMed |
| 11 | 16254965 | Antigenicity and immunogenicity of the immunodominant region of hepatitis B surface antigen displayed on bacteriophage T7. | J Med Virol | 2005 | https://conductscience.org/library/papers/16254965 | PubMed |
| 12 | 19729082 | Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses. | Vaccine | 2009 | https://conductscience.org/library/papers/19729082 | PubMed |
| 13 | 19417736 | Antitumor activity of endogenous mFlt4 displayed on a T4 phage nanoparticle surface. | Acta Pharmacol Sin | 2009 | https://conductscience.org/library/papers/19417736 | PubMed |
| 14 | 1422008 | Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979. | Biotechnology | 1992 | https://conductscience.org/library/papers/1422008 | PubMed |
| 15 | 15100303 | Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. | J Immunol | 2004 | https://conductscience.org/library/papers/15100303 | PubMed |
| 16 | 5432063 | Cleavage of structural proteins during the assembly of the head of bacteriophage T4. | Nature | 1970 | https://conductscience.org/library/papers/5432063 | PubMed |
| 17 | 10051649 | Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10051649 | PubMed |
| 18 | 3794607 | IgG2a restriction of murine antibodies elicited by viral infections. | J Exp Med | 1987 | https://conductscience.org/library/papers/3794607 | PubMed |
| 19 | 17215048 | T7 phage display of Ep15 peptide for the detection of WNV IgG. | J Virol Methods | 2007 | https://conductscience.org/library/papers/17215048 | PubMed |
| 20 | 18081037 | Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design. | Eur J Immunol | 2008 | https://conductscience.org/library/papers/18081037 | PubMed |
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 75 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41777249 | Bacteriophage Therapy: Current Strategies and Future Perspectives. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/41777249 | PubMed |
| 41012191 | Advances in Biotechnology and the Development of Novel Human Vaccines. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41012191 | PubMed |
| 40872508 | Bacteriophage Therapy: Discovery, Development, and FDA Approval Pathways. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40872508 | PubMed |
| 39455641 | Designing a multi-epitope influenza vaccine: an immunoinformatics approach. | Sci Rep | 2024 | https://conductscience.org/library/papers/39455641 | PubMed |
| 39350170 | Use of virus-like particles and nanoparticle-based vaccines for combating picornavirus infections. | Vet Res | 2024 | https://conductscience.org/library/papers/39350170 | PubMed |
| 39335043 | A Comprehensive Review on Phage Therapy and Phage-Based Drug Development. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39335043 | PubMed |
| 38528300 | Evaluation of immunogenicity and protective efficacy of bacteriophage conjugated haemagglutinin based subunit vaccine against equine influenza virus in a murine model. | Vet Res Commun | 2024 | https://conductscience.org/library/papers/38528300 | PubMed |
| 37809683 | Phage based vaccine: A novel strategy in prevention and treatment. | Heliyon | 2023 | https://conductscience.org/library/papers/37809683 | PubMed |
| 37424789 | SpyTag/SpyCatcher display of influenza M2e peptide on norovirus-like particle provides stronger immunization than direct genetic fusion. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/37424789 | PubMed |
| 36925687 | Phage engineering and phage-assisted CRISPR-Cas delivery to combat multidrug-resistant pathogens. | Bioeng Transl Med | 2023 | https://conductscience.org/library/papers/36925687 | PubMed |
| 35320040 | A single-shot vaccine approach for the universal influenza A vaccine candidate M2e. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/35320040 | PubMed |
| 34918242 | Phage T7 as a Potential Platform for Vaccine Development. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/34918242 | PubMed |
| 34841341 | The bacteriophage decides own tracks: When they are with or against the bacteria. | Curr Res Microb Sci | 2021 | https://conductscience.org/library/papers/34841341 | PubMed |
| 34804430 | Intranasal administration of immunogenic poly-epitope from influenza H1N1 and H3N2 viruses adjuvanted with chitin and chitosan microparticles in BALB/c mice. | Iran J Basic Med Sci | 2021 | https://conductscience.org/library/papers/34804430 | PubMed |
| 34712234 | Bacteriophage T4 Vaccine Platform for Next-Generation Influenza Vaccine Development. | Front Immunol | 2021 | https://conductscience.org/library/papers/34712234 | PubMed |
| 33916345 | Bacteriophages as Potential Tools for Use in Antimicrobial Therapy and Vaccine Development. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/33916345 | PubMed |
| 33603072 | Broad cross protection by recombinant live attenuated influenza H3N2 seasonal virus expressing conserved M2 extracellular domain in a chimeric hemagglutinin. | Sci Rep | 2021 | https://conductscience.org/library/papers/33603072 | PubMed |
| 33430278 | The Next Generation of Influenza Vaccines: Towards a Universal Solution. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/33430278 | PubMed |
| 32899720 | Bacteriophage-Based Vaccines: A Potent Approach for Antigen Delivery. | Vaccines (Basel) | 2020 | https://conductscience.org/library/papers/32899720 | PubMed |
| 32882637 | Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope. | Virology | 2020 | https://conductscience.org/library/papers/32882637 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FLNB | 2317 | PubTator's text mining | https://conductscience.org/library/genes/2317 | NCBI Gene |
| HLA-C | 3107 | PubTator's text mining | https://conductscience.org/library/genes/3107 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| TLR5 | 7100 | PubTator's text mining | https://conductscience.org/library/genes/7100 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23029232
GET https://conductscience.org/api/papers/v1/23029232/references?page=2